Report Detail

Pharma & Healthcare Global Dermatophytosis Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541467
  • |
  • 06 November, 2018
  • |
  • Global
  • |
  • 117 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Dermatophytosis Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Dermatophytosis Treatment Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Rx
  • 1.2.2 OTC
  • 1.3 Market Analysis by Applications
  • 1.3.1 Hospital
  • 1.3.2 Clinic
  • 1.3.3 Other
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Novartis
    • 2.1.1 Business Overview
  • 2.1.2 Dermatophytosis Treatment Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Novartis Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Pfizer
  • 2.2.1 Business Overview
  • 2.2.2 Dermatophytosis Treatment Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Pfizer Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Sanofi-Aventis
  • 2.3.1 Business Overview
  • 2.3.2 Dermatophytosis Treatment Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Sanofi-Aventis Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Merck
  • 2.4.1 Business Overview
  • 2.4.2 Dermatophytosis Treatment Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Merck Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Enzon Pharmaceuticals
  • 2.5.1 Business Overview
  • 2.5.2 Dermatophytosis Treatment Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Enzon Pharmaceuticals Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Bayer
  • 2.6.1 Business Overview
  • 2.6.2 Dermatophytosis Treatment Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Bayer Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Astellas Pharma
  • 2.7.1 Business Overview
  • 2.7.2 Dermatophytosis Treatment Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Astellas Pharma Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 GSK
  • 2.8.1 Business Overview
  • 2.8.2 Dermatophytosis Treatment Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 GSK Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Abbott
  • 2.9.1 Business Overview
  • 2.9.2 Dermatophytosis Treatment Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Abbott Dermatophytosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Dermatophytosis Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Dermatophytosis Treatment Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Dermatophytosis Treatment Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Dermatophytosis Treatment Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Dermatophytosis Treatment Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Dermatophytosis Treatment Market Analysis by Regions

    • 4.1 Global Dermatophytosis Treatment Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Dermatophytosis Treatment Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Dermatophytosis Treatment Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 4.3 Europe Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 4.5 South America Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 5 North America Dermatophytosis Treatment by Countries

    • 5.1 North America Dermatophytosis Treatment Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Dermatophytosis Treatment Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Dermatophytosis Treatment Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 5.3 Canada Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 6 Europe Dermatophytosis Treatment by Countries

    • 6.1 Europe Dermatophytosis Treatment Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Dermatophytosis Treatment Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Dermatophytosis Treatment Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 6.3 UK Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 6.4 France Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 6.5 Russia Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 6.6 Italy Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Dermatophytosis Treatment by Countries

    • 7.1 Asia-Pacific Dermatophytosis Treatment Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Dermatophytosis Treatment Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Dermatophytosis Treatment Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 7.3 Japan Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 7.4 Korea Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 7.5 India Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 8 South America Dermatophytosis Treatment by Countries

    • 8.1 South America Dermatophytosis Treatment Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Dermatophytosis Treatment Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Dermatophytosis Treatment Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Dermatophytosis Treatment by Countries

    • 9.1 Middle East and Africa Dermatophytosis Treatment Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Dermatophytosis Treatment Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Dermatophytosis Treatment Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 9.3 UAE Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Dermatophytosis Treatment Sales and Growth Rate (2013-2018)
  • 10 Global Dermatophytosis Treatment Market Segment by Type

    • 10.1 Global Dermatophytosis Treatment Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Dermatophytosis Treatment Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Dermatophytosis Treatment Revenue and Market Share by Type (2013-2018)
  • 10.2 Rx Sales Growth and Price
  • 10.2.1 Global Rx Sales Growth (2013-2018)
  • 10.2.2 Global Rx Price (2013-2018)
  • 10.3 OTC Sales Growth and Price
  • 10.3.1 Global OTC Sales Growth (2013-2018)
  • 10.3.2 Global OTC Price (2013-2018)
  • 11 Global Dermatophytosis Treatment Market Segment by Application

    • 11.1 Global Dermatophytosis Treatment Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Sales Growth (2013-2018)
    • 11.3 Clinic Sales Growth (2013-2018)
    • 11.4 Other Sales Growth (2013-2018)

    12 Dermatophytosis Treatment Market Forecast (2018-2023)

    • 12.1 Global Dermatophytosis Treatment Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Dermatophytosis Treatment Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Dermatophytosis Treatment Market Forecast (2018-2023)
  • 12.2.2 Europe Dermatophytosis Treatment Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Dermatophytosis Treatment Market Forecast (2018-2023)
  • 12.2.4 South America Dermatophytosis Treatment Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Dermatophytosis Treatment Market Forecast (2018-2023)
  • 12.3 Dermatophytosis Treatment Market Forecast by Type (2018-2023)
  • 12.3.1 Global Dermatophytosis Treatment Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Dermatophytosis Treatment Market Share Forecast by Type (2018-2023)
  • 12.4 Dermatophytosis Treatment Market Forecast by Application (2018-2023)
  • 12.4.1 Global Dermatophytosis Treatment Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Dermatophytosis Treatment Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Ringworm on the skin like athlete's foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.

      Scope of the Report:

      The worldwide market for Dermatophytosis Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      This report focuses on the Dermatophytosis Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers

      Novartis

      Pfizer

      Sanofi-Aventis

      Merck

      Enzon Pharmaceuticals

      Bayer

      Astellas Pharma

      GSK

      Abbott

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Rx

      OTC

      Market Segment by Applications, can be divided into

      Hospital

      Clinic

      Other

      There are 15 Chapters to deeply display the global Dermatophytosis Treatment market.

      Chapter 1, to describe Dermatophytosis Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Dermatophytosis Treatment, with sales, revenue, and price of Dermatophytosis Treatment, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatophytosis Treatment, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Dermatophytosis Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Dermatophytosis Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


      Summary:
      Get latest Market Research Reports on Dermatophytosis Treatment . Industry analysis & Market Report on Dermatophytosis Treatment is a syndicated market report, published as Global Dermatophytosis Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Dermatophytosis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,867.21
      4,300.82
      5,734.43
      3,136.08
      4,704.12
      6,272.16
      369,690.84
      554,536.26
      739,381.68
      248,117.74
      372,176.60
      496,235.47
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report